Ties to Big Pharma abortion pill maker

Facebooktwittergoogle_plusredditpinterestlinkedinmail

(Natural News) Kavanaugh accuser Christine Blasey Ford, who claims — without any evidence — that Kavanaugh inappropriately touched her at a drunken party while in high school, turns out to have ties to an abortion pill pharmaceutical company called Corcept Therapeutics. This discovery brings to light an obvious conflict of interest in Blasey’s story, revealing that she works for a pharmaceutical company that manufacturers an abortion pill drug, whose profits could be strongly impacted by future Supreme Court decisions on abortion rights.

Corcept Therapeutics (Corcept.com) manufacturers and markets an abortion pill drug called mifepristone, and Christine Blasey Ford is a co-author of at least eight published scientific papers produced by the pharmaceutical giant to promote its pills. You can see Blasey’s name listed on several publications at this Corcept.com web page detailing their research papers.

Corcept Therapeutics, Inc., a $166 billion market cap company (stock symbol CORT) reportedly has current annual sales of $216 million. The company offers just one drug, mifepristone, which is widely known as an “abortion pill” or RU-486. Many drugs have multiple uses, and mifepristone — brand name “Korlym” at Corcept — is currently marketed by the company for the treatment of Cushing’s syndrome. (h/t to The Gateway Pundit for initial work on this breaking story.)

Like all FDA-approved drugs, mifepristone is frequently prescribed off-label, meaning doctors prescribe it for conditions that it has never been approved to treat. It is well known throughout the medical industry that doctors routinely prescribe this drug to terminate unwanted pregnancies. It is a covert “abortion drug,” in other words.

If Kavanaugh were to be confirmed on the U.S. Supreme Court and be part of a decision that overturns Roe vs. Wade, it would make the prescribing of Corcept’s drug for abortion illegal, directly impacting the bottom line profits of the company for which Christine Blasey works.

See this Medscape explanation of how this abortion pill works, where it explains the drug is “Indicated for the medical termination of intrauterine pregnancy through 70 days gestation in combination with misoprostol.”

The Corcept company even issues a strong warning about its abortion potential on its marketing website, offering the “warning” as a wink, wink message to doctors that this is actually an abortion pill.

The “warning” explains:

Mifepristone is a potent antagonist of progesterone and cortisol via the progesterone and glucocorticoid (GR-II) receptors, respectively. The antiprogestational effects will result in the termination of pregnancy.

“Mifepristone, also known as RU-486, is a medication typically used in combination with misoprostol, to bring about an abortion. This combination is more than 95% effective during the first 50 days of pregnancy,” says the Wikipedia entry on mifepristone. The World Health Organization currently promotes the drug as an abortion pill, calling it “safe and effective.” (Safe for the mother, not the child, of course.)

Christine Blasey scrubs her internet history to eliminate evidence of hazy, drunken sex parties documented in her high school yearbook

Christine Blasey Ford, whose middle name is Margaret, is known as “Blasey CM” on the science papers she’s published with Corcept Therapeutics.

Before going public with her baseless accusations against Brett Kavanaugh, Christine Blasey scrubbed her internet history, removing her Linked In pages and even managing to have her entire high school year book completely removed from the internet. (Natural News has now posted the recovered yearbook files at this link – PDF.) As InfoWars reports, the high school yearbook of Christine Blasey is full of accounts of wild, drunken sex parties attended by Blasey and others:

“And there were always parties to celebrate any occasion,” reads one passage. “Although these parties are no doubt unforgettable, they are only a memory lapse for most, since loss of consciousness is often an integral part of the party scene.”

The reasons for Blasey working so hard to scrub her own history are obvious: Even while she claims that Kavanaugh’s history should be researched and brought to light, she didn’t want anyone looking into her own history, including her wild, alcohol-induced party days and her ties with Corcept Therapeutics and its abortion pill drug profits.

But the ties cannot elude internet researchers like Natural News. A Palo Alto University document from 2015 (see page 97) confirms that Christine Blasey, Ph.D. is a professor at Palo Alto University and a “Director of Biostatistics at Corcept Therapeutics.” See the screen shot from that document:

Blasey is the co-author of numerous published studies funded by Corcept

Blasey also appears on numerous published studies at PubMed, where her author ID is 19888560. These studies are all funded by Corcept Therapeutics of Menlo Park, CA. They all center around uses of mifepristone for uses beyond the typical “abortion pill” application. They include studies such as:

Mifepristone treatment of olanzapine-induced weight gain in healthy men

Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men

Efficacy and safety of mifepristone for the treatment of psychotic depression – this study seeks to support the use of mifepristone as an antidepressant drug, demonstrating that Blasey is also engaged in Big Pharma’s pursuit to push more drugs for mental health disorders.

Some of Blasey’s colleagues in this pharmaceutical research include Coleman Gross, Dr. Henry Fein, Dr. T. Brooks Vaughan III and Dat Nguyen.

This P.R. announcement from Corcept, intended to entice investors, states that, “Corcept is exploring mifepristone (the active ingredient in Korlym) as a treatment for triple-negative breast cancer with a multi-center, Phase I clinical study currently underway in patients with metastatic or locally advanced unresectable breast cancer. It is also supporting investigator-led clinical studies of mifepristone in the treatment of ovarian cancer and castration-resistant prostate cancer.”

Furthermore, the company is also working to get FDA approval for mifepristone in the treatment of psychiatric disorders, saying, “[The company] owns or has licensed extensive intellectual property covering the use of GR antagonists, including mifepristone, in the treatment of a wide variety of metabolic and psychiatric disorders and triple-negative breast cancer.”

What’s clear is that Corcept is working to aggressively expand the approved uses of its drug, obviously in an effort to increase prescriptions and profits.

See the full details of this story in our REAL.video report

The full details of this article, by the way, are available in this REAL.video report, just filed today:

REAL.video/5837766151001

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Leave a Reply

You must be logged in to post a comment.